Jay Matushak - Net Worth and Insider Trading

Jay Matushak Net Worth

The estimated net worth of Jay Matushak is at least $55,359 dollars as of 2024-05-28. Jay Matushak is the CFO of NeueHealth Inc and owns about 9,304 shares of NeueHealth Inc (NEUE) stock worth over $55,359. Details can be seen in Jay Matushak's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jay Matushak has not made any transactions after 2024-05-10 and currently still holds the listed stock(s).

Transaction Summary of Jay Matushak

To

Jay Matushak Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jay Matushak owns 1 companies in total, including NeueHealth Inc (NEUE) .

Click here to see the complete history of Jay Matushak’s form 4 insider trades.

Insider Ownership Summary of Jay Matushak

Ticker Comapny Transaction Date Type of Owner
NEUE NeueHealth Inc 2024-05-10 Chief Financial Officer

Jay Matushak Latest Holdings Summary

Jay Matushak currently owns a total of 1 stock. Jay Matushak owns 9,304 shares of NeueHealth Inc (NEUE) as of May 10, 2024, with a value of $55,359.

Latest Holdings of Jay Matushak

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NEUE NeueHealth Inc 2024-05-10 9,304 5.95 55,359

Holding Weightings of Jay Matushak


Jay Matushak Form 4 Trading Tracker

According to the SEC Form 4 filings, Jay Matushak has made a total of 6 transactions in NeueHealth Inc (NEUE) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in NeueHealth Inc is the sale of 317 shares on May 10, 2024, which brought Jay Matushak around $1,918.

Insider Trading History of Jay Matushak

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jay Matushak Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jay Matushak Ownership Network

Ownership Network List of Jay Matushak

No Data

Ownership Network Relation of Jay Matushak


Jay Matushak Owned Company Details

What does NeueHealth Inc do?

Who are the key executives at NeueHealth Inc?

Jay Matushak is the Chief Financial Officer of NeueHealth Inc. Other key executives at NeueHealth Inc include Chief Accounting Officer Jeffrey J Scherman , director & CEO and President Mikan George Lawrence Iii , and GC & CORPORATE SECRETARY Jeff Michael Craig .

NeueHealth Inc (NEUE) Insider Trades Summary

Over the past 18 months, Jay Matushak made 6 insider transaction in NeueHealth Inc (NEUE) with a net sale of 3,407. Other recent insider transactions involving NeueHealth Inc (NEUE) include a net sale of 51,823 shares made by Jeffrey J Scherman , a net sale of 451,635 shares made by Mikan George Lawrence Iii , and a net sale of 21,838 shares made by Jeff Michael Craig .

In summary, during the past 3 months, insiders sold 39,142 shares of NeueHealth Inc (NEUE) in total and bought 0 shares, with a net sale of 39,142 shares. During the past 18 months, 645,531 shares of NeueHealth Inc (NEUE) were sold and 585,000 shares were bought by its insiders, resulting in a net sale of 60,531 shares.

NeueHealth Inc (NEUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NeueHealth Inc Insider Transactions

No Available Data

Jay Matushak Mailing Address

Above is the net worth, insider trading, and ownership report for Jay Matushak. You might contact Jay Matushak via mailing address: C/o Bright Health Group, Inc., 8000 Norman Center Drive, Suite 900, Minneapolis Mn 55437.

Discussions on Jay Matushak

No discussions yet.